Emergency contraception - clinical and ethical aspects

dc.creatorFaundes, A
dc.creatorBrache, V
dc.creatorAlvarez, E
dc.date2003
dc.dateSEP
dc.date2014-11-17T05:28:35Z
dc.date2015-11-26T16:52:20Z
dc.date2014-11-17T05:28:35Z
dc.date2015-11-26T16:52:20Z
dc.date.accessioned2018-03-28T23:39:15Z
dc.date.available2018-03-28T23:39:15Z
dc.identifierInternational Journal Of Gynecology & Obstetrics. Elsevier Sci Ireland Ltd, v. 82, n. 3, n. 297, n. 305, 2003.
dc.identifier0020-7292
dc.identifierWOS:000185867600006
dc.identifier10.1016/S0020-7292(03)00221-2
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/64685
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/64685
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/64685
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1276251
dc.descriptionEmergency contraception (EC) consists of either 1.5 mg of levonorgestrel (LNG) in one or two doses, or a combination of LNG with ethinylestradiol, administered for up to 5 days after unprotected intercourse. Clinical studies indicate that LNG alone is more effective and has less side effects. Its effectiveness decreases the longer after coitus it is taken. EC is indicated when there is non-compliance or accidents with the use of regular methods of contraception, or when women have had voluntary or imposed unprotected intercourse. The ethics of providing EC has been questioned by some, arguing that it acts by preventing implantation. Scientific evidence does not support this concept, but shows that EC acts mostly before fertilization. Placing obstacles to the access of EC is unethical as it transgresses the ethical principles of autonomy, non-maleficence beneficence and justice. Far from inducing abortions, EC reduces unwanted pregnancies and prevents abortion. (C) 2003 International Federation of Gynecology and Obstetrics. Published by Elsevier Science Ireland Ltd. All rights reserved.
dc.description82
dc.description3
dc.description297
dc.description305
dc.languageen
dc.publisherElsevier Sci Ireland Ltd
dc.publisherClare
dc.publisherIrlanda
dc.relationInternational Journal Of Gynecology & Obstetrics
dc.relationInt. J. Gynecol. Obstet.
dc.rightsfechado
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.sourceWeb of Science
dc.subjectemergency contraception
dc.subjectlevonorgestrel
dc.subjecteffectiveness
dc.subjectmechanism of action
dc.subjectethics
dc.subjectPost-coital Contraception
dc.subjectYuzpe Regimen
dc.subjectPostcoital Contraception
dc.subjectEthinylestradiol Combination
dc.subjectDl-norgestrel
dc.subjectMifepristone Ru-486
dc.subjectRandomized Trial
dc.subjectFollicular Phase
dc.subjectLevonorgestrel
dc.subjectEndometrium
dc.titleEmergency contraception - clinical and ethical aspects
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución